Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome.

Source:http://linkedlifedata.com/resource/pubmed/id/16772347

Download in:

View as

General Info

PMID
16772347